Skip to main content
SpringerLink
Log in

Calcium antagonists

  • Chapter
Drugs for Heart Disease

  • 57 Accesses

Abstract

In the 20 years since the definition by Fleckenstein [1] of drugs selectively blocking the slow calcium channel in myocardial cells and realization of their clinical usefulness, there has been an outburst of pharmacological research producing new agents in this group. This has led to extensive argument as to which drugs are true calcium channel blockers and which prevent calcium ion entry to the cells by other mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fleckenstein, A. (1977) Specific pharmacology of calcium in myocardium, cardiac pacemakers and vascular smooth muscle. Ann. Rev. Pharmaco. Toxicol., 17 149–66.

    Article  CAS  Google Scholar 

  2. Opie, L.H. (1984) Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review. Quart. J. Med., 53, 1–16.

    PubMed  CAS  Google Scholar 

  3. Tomlinson, S., MacNeil, S., Walker, S.W., Ollis, C.A., Merritt, J.E. and Brown, B.L. (1984) Calmodulin and cell function. Clin. Sci., 66, 497–507.

    PubMed  CAS  Google Scholar 

  4. Braunwald, E. (1982) Mechanism of action of calcium-channel-blocking agents. N. Engl. J. Med., 307, 1618–27.

    Article  PubMed  CAS  Google Scholar 

  5. Kawai, C., Konishi, T., Matsuyama, E. and Okazaki, H. (1981) Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine on the sinoatrial and atrioventricular nodes. Experimental and clinical studies. Circulation, 63, 1035–42.

    Article  PubMed  CAS  Google Scholar 

  6. Drake-Holland, A.J., and Noble, M.I.M. (1983) Editorial: Myocardial protection by calcium antagonist drugs. Eur. Heart J., 4, 823–5.

    PubMed  CAS  Google Scholar 

  7. Meyer, H., Bossert, F., Wehinger, E., Towart, R. and Belleman, N.P. (1983) Chemistry of calcium antagonists. Hypertension, 5, 112–7.

    Article  Google Scholar 

  8. Henry, P.D. (1980) Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am. J. Cardiol., 46, 1047–56.

    Article  PubMed  CAS  Google Scholar 

  9. Belz, G.G., Aust, P.E. and Munkes, R. (1981) Digoxinplasma concentrations and nifedipine. Lancet, i, 844–5.

    Google Scholar 

  10. Nayler, W.G., Poole-Wilson, P.A. and Williams, A. (1979) Hypoxia and calcium. J. Mol. Cell Cardiol., 11, 683–706.

    Article  PubMed  CAS  Google Scholar 

  11. Baker, J.E. and Hearse, D.J. (1983) The temperature-sensitivity of slow channel calcium blockers in relation to their effect on the calcium paradox. Eur. Heart J., 4, Suppl. H, 97–103.

    Google Scholar 

  12. Clusin, W.T., Buchbinder, M. and Harrison, D.C. (1983) Calcium overload ‘injury’ current, and early iscahemic cardiac arrhythmias - a direct connection, Lancet, i, 272–4.

    Google Scholar 

  13. Bagger, J.P., Toftegaard-Nielsen, T. and Hennigsen, P. (1983) The effect of verapamil on myocardial exchange of free fatty acids, citrate lactate and glucose in coronary artery disease. Eur. Heart J., 4, 406–14.

    PubMed  CAS  Google Scholar 

  14. Smith, H.J., Goldstein, R.A., Griffith, J.M., Kent, K.M. and Epstein, S.E. (1976) Regional contractility: selective depression of ischemic myocardium by verapamil. Circulation, 54; 629–35.

    Article  PubMed  CAS  Google Scholar 

  15. The Danish study group on verapamil in myocardial infarction (1984) Verapamil in acute myocardial infarction. Eur. Heart J., 5, 516–28.

    Google Scholar 

  16. Brooks, W.W., Verrier, R. and Lown, B. (1980) Protective effects of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusion. Cardiovasc. Res., 14, 295–302.

    Article  PubMed  CAS  Google Scholar 

  17. Winslow, E., Marshall, R.J. and Hope, F.G. (1983) Comparative effects of fast and slow ion channel blocking agents on reperfusion-induced arrhythmias in the isolated perfused rat heart. J. Cardiovasc. Pharmacol., 5, 928–36.

    Article  PubMed  CAS  Google Scholar 

  18. Mason, J.W., Swerdlow, C.D. and Mitchell, L.B. (1983) Efficacy of verapamil in chronic, recurrent ventricular tachycardia. Am. J. Cardiol., 51, 1614–17.

    Article  PubMed  CAS  Google Scholar 

  19. Fazzini, P.F., Marchi, F., Pucci, P., Ledda, F. and Mugelli, A. (1979) Effects of verapamil on ventricular premature beats of acute myocardial infarction. Am. Heart J., 98, 816–18.

    Article  PubMed  CAS  Google Scholar 

  20. van Zweiten, P.A., van Meel, J.C.A. and Timmermans, P.B.M.W.M. (1983) Pharmacology of calcium entry blockers: interaction with vascular alphaadrenoceptors. Hypertension, 5, 118–17.

    Google Scholar 

  21. Johnston, A., Burgess, C.D. and Hamer, J. (1981) Systematic availability of oral verapamil and effect on PR interval in man. Brit. J. Clin. Pharmacol., 12, 397–400.

    Article  CAS  Google Scholar 

  22. Shand, D.G., Hammill, S.C., Aanonsen, L. and Pritchett, E.L.C. (1981) Reduced verapamil clearance during long-term oral dministration. Clin. Pharm. Ther., 30, 701–3.

    Article  CAS  Google Scholar 

  23. Somogyi, A., Albrecht, M., Kleims, G., Schafter, K. and Eichelbaum, M. (1981) Pharmacokinetics, bioavailabilities, and ECG response to verapamil in patients with liver cirrhosis. Br. J. Clin. Pharmacol., 12, 51–60.

    Article  PubMed  CAS  Google Scholar 

  24. Eichelbaum, M., Mikas, G. and Vogelgesang, B. (1984) Pharmacokinetics at (+)- (-)- and (±)-verapamil after intravenous administration. Br. J. Clin. Pharmacol., 17, 453–8.

    Article  PubMed  CAS  Google Scholar 

  25. Vlietstra, R.E., Farias, M.A.C., Frye, R.L., Smith, H.C. and Ritman, E.L. (1983) Effect of verapamil on left ventricular function: a randomized placebo-controlled study. Am. J. Cardiol., 51, 1213–17.

    Article  PubMed  CAS  Google Scholar 

  26. Packer, M., Meiler, J., Medina, N., Yushak, M., Smith, H., Holt, J., Guererro J., Todd, G.D., McAllister, R.G. and Gorlin, R. (1982) Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man. Circulation, 65, 660–8.

    Article  PubMed  CAS  Google Scholar 

  27. Woie, L. and Storstein, L. (1981) Successful treatment of suicidal verapamil poisoning with calcium gluconate. Eur. Heart J., 2, 239–42.

    PubMed  CAS  Google Scholar 

  28. Gmeiner, R. and Ng, C.K. (1981) Effect of tiapamil in the Wolff-ParkinsonWhite syndrome. J. Cardiovasc. Pharmacol, 3, 237–50.

    Article  PubMed  CAS  Google Scholar 

  29. Flammang, D., Waynberger, M., Jansen, F.H., Paillet, R. and Courmel, Ph. (1983) Electrophysiological profile of bepridil, a new anti-anginal drug with calcium blocking properties. Eur. Heart J., 4, 647–54.

    Google Scholar 

  30. Maclean, D. and Feely, J. (1983) Calcium antagonists, nitrates, and new antianginal drugs. Br. Med. J., 286, 1127–30.

    Article  CAS  Google Scholar 

  31. Robinson, B.F., Dobbs, R.J. and Kelsey, C.R. (1980) Effects of nifedipine on resistance vessels, arteries and veins in man. Br. J. Clin. Pharmacol, 10, 433–8.

    Article  PubMed  CAS  Google Scholar 

  32. Raemsch, K.D. and Sommer, J. (1983) Pharmacokinetics and metabolism of nifedipine. Hypertension, 5, II18–II24.

    Google Scholar 

  33. Charles, S., Ketelslegers, J.-M. Buysschaert, M. and Lambert, A.E. (1981) Hyperglycaemic effect of nifedipine. Br. Med. J., 283, 19–20.

    Article  CAS  Google Scholar 

  34. Joshi, P.I., Dalai, J.J., Ruttley, M.S.J., Sheridan, D.J. and Henderson, A.H. (1981) Nifedipine and left ventricular function in beta-blocked patients. Br. Heart J., 45, 457–9.

    Article  PubMed  CAS  Google Scholar 

  35. Opie, L.H. and White, D.A. (1980) Adverse interaction between nifedipine and beta-blockade. Br. Med. J., 281, 1462.

    Article  PubMed  CAS  Google Scholar 

  36. Harris, L., Dargie, H.J., Lynch, P.G., Bulpitt, C.J. and Krikler, D.M. (1982) Blood pressure and heart rate in patients with ischaemic heart disease receiving nifedipine and propranolol. Br. Med. J., 284, 1148–51.

    Article  CAS  Google Scholar 

  37. Iliopoulou, A., Turner, P. and Warrington, S.J. (1983) Acute haemodynamic effects of a new calcium antagonist, nicardipine, in man. A comparison with nifedipine. Br. J. Clin. Pharmacol., 15, 59–66.

    Article  PubMed  CAS  Google Scholar 

  38. Hansson, L., Andren, L., Oro, L. and Ryman, T. (1983) Pharmacokinetic and pharmacodynamic parameters in patients treated with nitrendipine. Hypertension, 5, I125–1128.

    Google Scholar 

  39. Allen, G.S., Ahn, H.S., Preziosi, T.J., Battye, R., Boone, S.C., Chou, S.N., Kelly, D.L., Weir, B.K., Crabbe, R.A., Lavik, P.J., Rosenbloom, S.B., Dorsey, F.C., Ingram, C.R., Mellits, D.E., Bertsch, L.A., Boisvert, D.P.J., Hundley, M.B., Johnson, R.K., Strom, J. A. and Transou, C.R. (1983) Cerebral arterial spasm–a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N. Engl. J. Med., 308, 619–24.

    Article  PubMed  CAS  Google Scholar 

  40. Tweddel, A.C., Johnsson, G., Pringle, T.H., Murray, R.G., and Hutton, I. (1983) The systemic coronary haemodynamic effects of felodipine in patients with coronary heart disease. Eur. Heart J., 4, 699–705.

    PubMed  CAS  Google Scholar 

  41. Smith, M.S., Verghese, C.P., Shand, D.G. and Pritchett, E.L.C. (1982) Pharmacokinetic and pharmacodynamic effects of diltiazem. Am. J. Cardiol., 51, 1369–74.

    Article  Google Scholar 

  42. Valette, H. and Apoil, E. (1980) Haemodynamic effects of dilitiazem in healthy volunteers. Br. J. Clin. Pharamcol., 10, 623–4.

    Article  CAS  Google Scholar 

  43. Hossack, K.F. (1982) Conduction abnormalities due to diltiazem. N. Engl. J. Med., 307, 953–4.

    PubMed  CAS  Google Scholar 

  44. Grenadier, E., Keidar, S., Alpan, G., Marmor, A. and Palant A. (1980) Prenylamine-induced ventricular tachycardia and syncope controlled by ventricular pacing. Br. Heart J., 44, 330–4.

    Article  PubMed  CAS  Google Scholar 

  45. Shah, R.R., Oates, N.S., Idle, J.R., Smith, R.L. and Lockhart, J.D.F. (1982) Impaired oxidation of debrisoquine in patients with perhexiline neuropathy. Br. Med. J., 284, 295–9.

    Article  CAS  Google Scholar 

  46. Dawes, F. and Moulder, C. (1982) Perhexiline hepatitis and HLA B8. Lancet, ii, 109.

    Google Scholar 

  47. Sebille, A. (1978) Prevalence of latent perhexiline neuropathy. Br. Med. J., i, 1321–2.

    Google Scholar 

  48. Horgan, J.H., O’Callaghan, W.G. and Tee, K.K. (1981) Therapy of angina pectoris with low-dose perhexiline. J. Cardiovasc. Pharmacol., 3, 566–72.

    Article  PubMed  CAS  Google Scholar 

  49. Holmes, B., Brodgen, R.N., Heel, R.C., Speight, T.M. and Avery, G.S. (1984) Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs, 27, 6 44.

    Google Scholar 

  50. Towse, G. (ed.) (1980) Myocardial protection and exercise tolerance: the role of lidoflazine a new anti-anginal agent. Roy. Soc. Med. Int. Congr. Symp. Series, 29.

    Google Scholar 

  51. Hanley, S.P. and Hampton, J.R. (1983) Ventricular arrhythmias associated lidoflazine: side-effects observed in a randomized trial. Eur. Heart J., 4, 889–93.

    PubMed  CAS  Google Scholar 

  52. Valette, H., Barnay, C., Lopez, M., Hebert, J.L., Gallet, M., Apoil, E., Moyse, D. and Medvedowsky, J.L. (1983) Effect of intravenous diltiazem on sinus node function and atrioventricular conduction in patients. J. Cardiovasc. Pharmacol., 5, 62–6.

    Article  PubMed  CAS  Google Scholar 

  53. Rowland, E., Evans, T. and Krikler, D.M. (1979) Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac-electrophysiological study. Br. Heart J., 42, 126–7.

    Article  Google Scholar 

  54. Mitchell, L.B., Jutzy, K.R., Lewis, S.J., Schroeder, J.S. and Mason, J.W. (1982) Intracardiac electrophysiological study of intravenous diltiazem and combined diltiazem-digoxin in patients. Am. Heart J., 103, 57–66.

    Article  PubMed  CAS  Google Scholar 

  55. Harper, R.W., Whitford, E., Middlebrook, K., Federman, J., Anderson, S. and Pitt, A. (1982) Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome. Am. J. Cardiol., 50, 1323–30.

    Article  PubMed  CAS  Google Scholar 

  56. Lang, R., Klein, H.O., DiSegni, E., Gefen, J., Sareli, P., Libhaber, C., David, D., Weiss, E., Guerrero, J. and Kaplinsky, E. (1983) Verapamil improves exercise capacity in chronic atrial fibrillation: double-blind crossover study. Am. Heart J., 105, 820–5.

    Article  PubMed  CAS  Google Scholar 

  57. Johnson, S.M., Mauristen, D.F., Willerson, J.T. and Hillis, L.D. (1981) A controlled trial of verapamil for Prinzmetal’s variant angina. N. Engl. J. Med., 304, 862–6.

    Article  PubMed  CAS  Google Scholar 

  58. Yasue, H., Omote, S., Takizawa, A., Nagao, M., Miwa, K. and Tanaka, S. (1979) Exertional angina pectoris caused by coronary arterial spasm: effects of various drugs. Am. J. Cardiol., 43, 647–52.

    Article  PubMed  CAS  Google Scholar 

  59. Editorial (1984) Nitrates and angina. Lancet, i, 998–9.

    Google Scholar 

  60. McIlwraith, G.R., Kidner, P.H. and Oram, S. (1980) Effect of nifedipine on exercise tolerance in angina pectoris. Br. Heart J., 44, 335–341.

    Article  PubMed  CAS  Google Scholar 

  61. Lown, B. (ed.) (1979) Symposium on nifedipine and calcium flux inhibition in the treatment of coronary arterial spasm and myocardial ischemia. Am. J. Cardiol., 44, 779–844.

    Google Scholar 

  62. Winniford, M.D., Johnson, S.M., Mauritson, D.R. and Hillis, L.D. (1983) Ergonovine provocation to assess efficacy of long-term therapy with calcium antagonists in Prinzmetal’s variant angina. Am. J. Cardiol., 51, 684–8.

    Article  PubMed  CAS  Google Scholar 

  63. Gerstenblith, G., Ouyang, P., Achuff, S.C., Bulkley, B.H., Becker, L.C., Mellits, E.D., Baughman, K.L., Weiss, J.L., Flaherty, J.T., Kallman, C.H., Llewellyn, M. and Weisfedlt, M.L. (1982) Nifedipine in unstable angina. A double-blind randomized trial. N. Engl. J. Med., 306, 885–9.

    Article  PubMed  CAS  Google Scholar 

  64. Thuesen, L., Jorgensen, J.R., Kvistgaard, H.J., Sorensen, J.A., Vaeth, M., Jensen, E.B., Jensen, J.J. and Hagerup, L. (1983) Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: double blind randomised trial. Br. Med. J., 286, 1107–8.

    Article  CAS  Google Scholar 

  65. Lehmann, H.-U., Hochrein, H., Witt, E. and Mies, H.W. (1983) Hemodynamic effects of calcium antagonists. Rev. Hypertension, 5, I166–1173.

    Article  Google Scholar 

  66. Zacca, N.M., Verani, M.S., Chahine, R.A. and Miller, R.R. (1982) Effect of nifedipine on exercise-induced left ventricular dysfuntion and myocardial hypoperfusion in stable angina. Am. J. Cardiol., 50, 689–95.

    Article  PubMed  CAS  Google Scholar 

  67. Serruys, P.W., Hooghoudt, T.E.M., Reiber, J.H.C., Slager, C., Brower, R.W. and Hugenholtz, P.G. (1983) Influence of intravenous nifedipine on left ventricular function, coronary vasomotility and myocardial oxygen consumption. Br. Heart J., 49, 427–41.

    Article  PubMed  CAS  Google Scholar 

  68. Dagenais, G.R., Moisan, A., Marquis, Y., Davies, R.O. and Blouin, S. (1976) Effects of practolol on exercise tolerance, and cardiac haemodynamics and metabolism in patients with coronary artery disease. Cardiovasc. Res., 10, 25–36.

    Article  PubMed  CAS  Google Scholar 

  69. Schazenbacher, P., Liebau, G., Deeg, P. and Kochsiek, K. (1983) Effect of intravenous and intracoronary nifedipine on coronary blood flow and myocardial oxygen consumption. Am. J. Cardiol., 49, 442–6.

    Google Scholar 

  70. Stone, D.L., Stephens, J.D. and Banim, S.O. (1983) Coronary haemodynamic effects of nifedipine. Comparison with glyceryl trinitrate. Br. Heart J., 49, 422–6.

    Article  Google Scholar 

  71. Rouleau, J-L., Chatterjee, K., Ports, T.A., Doyle, M.B., Hiramatsu, B. and Parmley, W.W. (1983) Mechanism of relief of pacing-induced angina with oral verapamil: reduced oxygen demand. Circulation, 67, 94–100.

    Article  PubMed  CAS  Google Scholar 

  72. Klein, H.O., Ninio, R. Oren, V., Lang, R., Sareli, P., DiSegni, E. David, D., Guerrero, J. and Kaplinksy, E. (1983) The acute hemodynamic effects of intravenous verapamil in coronary artery disease: assessment of equilibrium-gated radionuclide ventriculography. Circulation, 67, 101–10.

    Article  PubMed  CAS  Google Scholar 

  73. Deanfield, J. Wright, C. and Fox, K. (1983) Treatment of angina pectoris with nifedipine: importance of dose titration. Br. Med. J., 286, 1467–70.

    Article  CAS  Google Scholar 

  74. Subramanian, V.B., Bowles, M.J., Khurmi, N.S., Davies, A.B., O’Hara, M.J. and Raftery, E.B. (1983) Calcium antagonist withdrawal syndrome: objective demonstration with frequency-modulated ambulatory ST-segment monitoring. Br. Med. J., 286, 520–1.

    Article  CAS  Google Scholar 

  75. Editorial (1983) Calcium-channel blockers and asthma. Thorax, 38, 481–5.

    Article  Google Scholar 

  76. Packer, M. and Frishman, H. (eds) (1982) Symposium on verapamil therapy for angina pectoris. Am. J. Cardiol., 50, 881–912, 913–28, 1153–95.

    Google Scholar 

  77. Bowles, M.J., Subramanian, V.B., Davies, A.B. and Raftery, E.B. (1981) Comparison of antianginal actions of verapamil and propranolol. Br. Med. J., 282, 1754.

    Article  CAS  Google Scholar 

  78. Subramanian, V.B., Bowles, M.J., Shurmi, N.S., Davies, A.B. and Raftery, E.B. (1982) Randomized double-blind comparison of verapamil and nifedipine in chronic stable angina. Am. J. Cardiol., 50, 696–703.

    Article  PubMed  CAS  Google Scholar 

  79. Wagniart, P., Ferguson, R.J., Cheitman, B.R., Achard, F., Benacerraf, A., Delanguenhagen, B., Morin, B., Pasternac, A. and Bourassa, M.G. (1982) Increased exercise tolerance and reduced electrocardiographic ischemia with diltiazem in patients with stable angina pectoris. Circulation, 66, 23–8.

    Article  PubMed  CAS  Google Scholar 

  80. Winniford, M.D., Markham, R.V., Firth, B.G., Nicod, P. and Hillis, L.D. (1982) Hemodynamic and electrophysiologic effects of verapamil and nifedipine in patients on propranolol. Am. J. Cardiol., 50, 704–10.

    Article  PubMed  CAS  Google Scholar 

  81. Robinson, B.F., Dobbs, R.J. and Bayley, S. (1982) Response of forearm resistance vessels to verapamil and sodium nitroprusside in normotensive and hypertensive men: evidence for a functional abnormality of vascular smooth muscle in primary hypertension. Clin. Sci., 63, 33–42.

    PubMed  CAS  Google Scholar 

  82. de Wardener, H.E. and MacGregor, G. (1983) Sodium efflux and essential hypertension. Lancet, i, 185–6.

    Google Scholar 

  83. Heagerty, A.M., Bing, R.F., Thurston, H. and Swales, J.D. (1983) Calcium antagonists in hypertension: relation to abnormal sodium transport. Br. Med. J., 287, 1405–7.

    Article  CAS  Google Scholar 

  84. Bianchetti, M.G. Beretta-Piccoli, C., Weidmann, P., Link, L., Boehringer, K., Ferrier, C. and Morton, J.J. (1983) Calcium and blood pressure regulation in normal and hypertensive subjects. Hypertension, 5, I157 - I165.

    Google Scholar 

  85. Erne, P., Bolli, P., Burgisser, E. and Buhler, F.R. (1984) Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. N. Engl. J. Med., 310, 1084–8.

    Article  PubMed  CAS  Google Scholar 

  86. McLeay, R.A.B., Stallard, T.J., Watson, R.D.S. and Littler, W.A. (1983) The effect of nifedipine on arterial pressure and reflex cardiac control. Circulation, 67, 1084–90.

    Article  PubMed  CAS  Google Scholar 

  87. Erne, P., Bolli, P., Bertel, O., Hulthen, L., Kiowski, W., Muller, F.B. and Buhgler, F. (1983) Factors influencing the hypotensive effects of calcium antagonists. Hypertension, 5, II97–II102.

    Google Scholar 

  88. Andersson, O., Bengtsson, C., Elmfedt, D., Haglund, K., Hedner, T., Seideman, P., Sjoberg, K.H., Stromgren, E., Aberg, H. and Ostman, J. (1984) Short-term effects of felodpine, a new dihydropyridine, in hypertension. Br. J. Clin. Pharmacol., 17, 257–63.

    Article  PubMed  CAS  Google Scholar 

  89. Simmonneau, G., Escourrou, P., Duroux, P. and Lockhart, A. (1981) Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N. Engl. J. Med., 304, 1582–5.

    Article  Google Scholar 

  90. Kennedy, T.P., Michael, J.R., Huang, C.-K., Kallman, C.H., Zahka, K., Schlott, W. and Sommer, W. (1984) Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled double-blind study. Am. Rev. Resp. Dis., 129, 544–51.

    PubMed  CAS  Google Scholar 

  91. Guazzi, M.D., Cipolla, C., Sganzerla, P., Agostoni, P.G., Fabbiocchi, F. and Pepi, M. (1983) Clinical use of calcium channel blockers as ventricular unloading agents. Eur. Heart J., 4, Suppl A, 181–7.

    Google Scholar 

  92. Factor, S.M. and Sonnenblick, E.H. (1982) Editorial. Hypothesis: is congestive cardiomyopathy caused by a hyperactive myocardial micro-circulation (microvascular spasm)? Am. J. Cardiol., 50, 1149–52.

    Article  PubMed  CAS  Google Scholar 

  93. Bellocci, F., Ansalone, G., Santarelli, P., Loperfido, F., Scabbia, E., Zecchi, P. and Manzoli, U. (1983) Oral nifedipine in the long-term management of severe chronic heart failure. J. Cardiovasc. Pharmacol., 4, 847–55.

    Article  Google Scholar 

  94. Brooks, N., Cattell, M., Pidgeon, J. and Balcon, R. (1980) Unpredictable response to nifedipine in severe cardiac failure. Br. Med. J., 281, 1324.

    Article  PubMed  CAS  Google Scholar 

  95. Alves, L.E. and Rose, E.P. (1982) Use of nifedipine in older patients and patients with congestive heart failure. Am. J. Med., 72, 462, 472.

    Google Scholar 

  96. Ferlinz, J. and Citron, P.D. (1983) Hemodynamic and myocardial performance characteristics after verapamil use in congestive heart failure. Am. J. Cardiol., 51, 1339–45.

    Article  PubMed  CAS  Google Scholar 

  97. Kinoshita, M., Kusukawa, R., Shimono, Y., Motomura, M., Tomonaga, G. and Hoshino, T. (1979) The effect of diltiazem hydrochloride upon sodium diuresis and renal function in chronic congestive heart failure. Arzneim. Forsch., 29, 676–81.

    CAS  Google Scholar 

  98. Timmis, A.D., Campbell, S., Monaghan, M.J., Walker, L. and Jewitt, D.E. (1984) Acute haemodynamic and metabolic effect of felodipine in congestive heart failure. Br. Heart J., 51, 445–51.

    Article  PubMed  CAS  Google Scholar 

  99. Given B.D., Lee, T.H., Stone, P.H. and Dzau, V.J. (1985) Nifedipine in severely hypertensive patients with congestive heart failure and preserved ventricular systolic function. Arch. Intern. Med., 141, 281–5.

    Article  Google Scholar 

  100. Rosing, D.R., Kent, K.M., Maron, B.J. and Epstein, S.E. (1979) Verapamil therapy: a new approach to the pharmacological treatment of hypertrophic cardiomyopathy. II Effects on exercise capacity and symptomatic status. Circulation, 60, 1208–13.

    Article  PubMed  CAS  Google Scholar 

  101. Kaltenbach, M., Hopf, R., Kober, G., Bussmann, W.-D., Keller, M. and Petersen, Y. (1979) Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Br. Heart J., 42, 35–42.

    Article  PubMed  CAS  Google Scholar 

  102. Epstein, S.E. and Roising, D.R. (1981) Verapamil: Its potential for causing serious complications in patients with hypertrophic cardiomyopathy. Circulation, 64, 437–41.

    Article  PubMed  CAS  Google Scholar 

  103. Landmark, K., Sire, S., Thaulow, E., Amile, J.P. and Nitter-Hauge, S. (1982) Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy. Br. Heart J., 48, 19–26.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. John Hamer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Formerly Consultant Cardiologist, now retired, Department of Clinical Pharmacology, St Bartholomew’s Hospital, EC1A 7BE, London, UK

    John Hamer MD. Ph.D F.R.C.P.

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Hamer, J. (1987). Calcium antagonists. In: Hamer, J. (eds) Drugs for Heart Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-3294-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-3294-5_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-412-26540-2

  • Online ISBN: 978-1-4899-3294-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation